Uninformed complementary and alternative supplement use: A risky behavior for cardiovascular patients

Complementary Health Practice Review

Volumn 13, Issue 2, 2008, Pages 100-109

  Bristol, Mirar N ^a   Sonnad, Seema S ^a   Guerra, Carmen ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Cardiovascular disease; Complementary therapies; Dietary supplements; Herb drug interactions

Indexed keywords

EID: 67650674696     PISSN: 15332101     EISSN: 15523845     Source Type: Journal    
DOI: 10.1177/1533210108317281     Document Type: Article

References (41)

1. American Heart Association. (2006a). Cardiac glossary. Retrieved February 2006, from http://www.americanheart.org/ presenter.jhtml?identifier=3038158#.
2. American Heart Association. (2006b). Cardiovascular disease statistics. Retrieved June 2006, from http://www.americanheart.org/ presenter.jhtml?identifier=4478.
3. Barnes, P.M., Powell-Griner, E., McFann, K., & Nahin, R.L. (2004, May 27). Complementary and alternative medicine use among adults: United States, 2002. Advance Data, (343), 1-19.
4. Cambria-Kiely, J.A. (2002). Effect of soy milk on warfarin efficacy. Annals of Pharmacotherapy, 36, 1893-1896.
5. Candelario-Jalil, E., Akundi, R.S., Bhatia, H.S., Lieb, K., Appel, K., Munoz, E., et al. (2006). Ascorbic acid enhances the inhibitory effect of aspirin on neuronal cyclooxygenase-2-mediated prostaglandin E2 production. Journal of Neuroimmunology, 174, 39-51.
6. Chagan, L., Ioselovich, A., Asherova, L., & Cheng, J.W. (2002). Use of alternative pharmacotherapy in management of cardiovascular diseases. American Journal of Managed Care, 8, 270-285.
7. Cherniack, E.P., Senzel, R.S., & Pan, C.X. (2001). Correlates of use of alternative medicine by the elderly in an urban population. Journal of Alternative and Complementary Medicine, 7, 277-280.
8. Cockayne, N.L., Duguid, M., & Shenfield, G.M. (2005). Health professionals rarely record history of complementary and alternative medicines. British Journal of Clinical Pharmacology, 59, 254-258.
9. Eisenberg, D.M., Davis, R.B., Ettner, S.L., Appel, S., Wilkey, S., Van Rompay, M., et al. (1998). Trends in alternative medicine use in the United States, 1990-1997: Results of a follow-up national survey. Journal of the American Medical Association, 280, 1569-1575.
10. Eisenberg, D.M., Kessler, R.C., Foster, C., Norlock, F.E., Calkins, D.R., & Delbanco, T.L. (1993). Unconventional medicine in the United States: Prevalence, costs, and patterns of use. New England Journal of Medicine, 328, 246-252.
11. Evans, V. (2000). Herbs and the brain: Friend or foe? The effects of ginkgo and garlic on warfarin use. Journal of Neuroscience Nursing: Journal of the American Association of Neuroscience Nurses, 32, 229-232.
12. Giveon, S.M., Liberman, N., Klang, S., & Kahan, E. (2003). A survey of primary care physicians' perceptions of their patients' use of complementary medicine. Complementary Therapies in Medicine, 11, 254-260.
13. Giveon, S.M., Liberman, N., Klang, S., & Kahan, E. (2004). Are people who use "natural drugs" aware of their potentially harmful side effects and reporting to family physician ? Patient Education and Counseling, 53, 5-11.
14. Grant, M.M., Barney, R.A., Wagner, P.J., Moseley, G.C., & Dianati, R. (2000). Alternative pharmacotherapy: Patterns of patient use and family physician practice. Journal of Family Practice, 49, 927-931.
15. Grauer, R.P., Thomas, R.D., Tronson, M.D., Heard, G.C., & Diacon, M. (2004). Preoperative use of herbal medicines and vitamin supplements. Anaesthesia and Intensive Care, 32, 173-177.
16. Hermann, D.D. (2002). Naturoceutical agents in the management of cardiovascular disease. Drugs, Devices, and Other Interventions, 2, 173-196.
17. Hunt, S.A., Abraham, W.T., Chin, M.H., Feldman, A.M., Francis, G.S., Ganiats, T.G., et al. (2005). ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation, 112, e154-e235.
18. Jayasekera, N., Moghal, A., Kashif, F., & Karalliedde, L. (2005). Herbal medicines and postoperative hemorrhage. Anaesthesia, 60, 725-726.
19. Jiang, X., Blair, E.Y., & McLachlan, A.J. (2006). Investigation of the effects of herbal medicines on warfarin response in healthy subjects: A population pharmacokinetic-pharmacodynamic modeling approach. Journal of Clinical Pharmacology, 46, 1370-1378.
20. Jiang, X., Williams, K.M., Liauw, W.S., Ammit, A.J., Roufogalis, B.D., Duke, C.C., et al. (2005). Effect of ginkgo and ginger on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects. British Journal of Clinical Pharmacology, 59, 425-432.
21. Kruth, P., Brosi, E., Fux, R., Morike, K., & Gleiter, C.H. (2004). Ginger-associated overanticoagulation by phenprocoumon. Annals of Pharmacotherapy, 38, 257-260.
22. Kurtzweil, P. (1998). An FDA guide to dietary supplements. FDA Consumer, 32, 28-35.
23. Lesho, E.P., Saullo, L., & Udvari-Nagy, S. (2004). A 76-year-old woman with erratic anticoagulation. Cleveland Clinic Journal of Medicine, 71, 651-656.
24. Macan, H., Uykimpang, R., Alconcel, M., Takasu, J., Razon, R., Amagase, H., et al. (2006). Aged garlic extract may be safe for patients on warfarin therapy. Journal of Nutrition, 136(Suppl.), 793S-795S.
25. McClaskey, E.M., & Michalets, E.L. (2007). Subdural hematoma after a fall in an elderly patient taking high-dose omega-3 fatty acids with warfarin and aspirin: Case report and review of the literature. Pharmacotherapy, 27, 152-160.
26. Metz, J.M., Jones, H., Devine, P., Hahn, S., & Glatstein, E. (2001). Cancer patients use unconventional medical therapies far more frequently than standard history and physical examination suggest. Cancer Journal, 7, 149-154.
27. Miller, K.L., Liebowitz, R.S., & Newby, L.K. (2004). Complementary and alternative medicine in cardiovascular disease: A review of biologically based approaches. American Heart Journal, 147, 401-411.
28. National Center of Complementary and Alternative Medicine, & National Institute of Health (NCCAM). (2006). The use of complementary and alternative medicine in the United States. Retrieved June 1, 2006, from http://nccam.nih.gov/news/camsurvey_fs1.htm#use.
29. NIH Office of Dietary Supplements. (2006a). NIH office of dietary supplements-dietary supplement fact sheets. Retrieved March 10, 2008, from http://ods.od.nih.gov/Health_Information/ Information_About_Individual_Dietary_Supplements.aspx.
30. NIH Office of Dietary Supplements. (2006b). NIH office of dietary supplements-Dietary supplement fact sheets. Retrieved March 10, 2008, from http://nccam.nih.gov/health/ginkgo/.
31. Robinson, A., & McGrail, M.R. (2004). Disclosure of CAM use to medical practitioners: A review of qualitative and quantitative studies. Complementary Therapies in Medicine, 12, 90-98.
32. Rossi, P., Di Lorenzo, G., Malpezzi, M.G., Faroni, J., Cesarino, F., Di Lorenzo, C., et al. (2005). Prevalence, pattern and predictors of use of complementary and alternative medicine (CAM) in migraine patients attending a headache clinic in Italy. Cephalalgia: An International Journal of Headache, 25, 493-506.
33. Rozenfeld, V., Crain, J.L., & Callahan, A.K. (2004). Possible augmentation of warfarin effect by glucosaminechondroitin. American Journal of Health-System Pharmacy, 61, 306-307.
34. Silverstein, D.D., & Spiegel, A.D. (2001). Are physicians aware of the risks of alternative medicine? Journal of Community Health, 26, 159-174.
35. Sparber, A., & Wootton, J.C. (2001). Surveys of complementary and alternative medicine: Part II. Use of alternative and complementary cancer therapies. Journal of Alternative and Complementary Medicine, 7, 281-287.
36. U.S. Food and Drug Administration, & Center for Food Safety and Applied Nutrition. (1995). U.S. FDA Dietary Supplement Health and Education Act of 1994. Rockville, MD: Author. Retrieved March 10, 2008, from http://www.cfsan.fda.gov/~dms/dietsupp.html.
37. U.S. General Accounting Office. (2001). "Anti-aging" products pose potential for physical and economic harm (Report to Chairman, Special Committee on Aging, U.S. Senate, No. GAO-01-1129). Washington, DC: Author. Retrieved March 10, 2008, from http://www.gao.gov/new.items/ d011129.pdf.
38. Wolf, H.R. (2006). Does ginkgo biloba special extract EGb 761 provide additional effects on coagulation and bleeding when added to acetylsalicylic acid 500 mg daily ? Drugs in R&D, 7, 163-172.
39. Wood, M.J., Stewart, R.L., Merry, H., Johnstone, D.E., & Cox, J.L. (2003). Use of complementary and alternative medical therapies in patients with cardiovascular disease. American Heart Journal, 145, 806-812.
40. Wootton, J.C., & Sparber, A. (2001). Surveys of complementary and alternative medicine: Part III. Use of alternative and complementary therapies for HIV/AIDS. Journal of Alternative and Complementary Medicine, 7, 371-377.
41. Zick, S.M., Blume, A., & Aaronson, K.D. (2005). The prevalence and pattern of complementary and alternative supplement use in individuals with chronic heart failure. Journal of Cardiac Failure, 11, 586-589.